How much does a course of durvalumab (durvalumab) treatment cost? Do prices vary depending on the length of treatment?

The treatment cost of durvalumab (durvalumab) in China has not yet been fully clarified, because the drug is not currently included in medical insurance, and the price is greatly affected by the region, hospital, and patient's purchasing channel. Common specifications are 120mg/2.4mL and 500mg/10mL, and each box sells for between more than 4,000 yuan to more than 10,000 yuan. The amount of medication required for a course of treatment usually depends on the patient's specific treatment plan and condition, and the length of the course of treatment will also have an impact on the final cost.

Typically, a durvalumab treatment cycle may involve taking the drug for several months. The cost of each course of treatment will be adjusted based on the length of the course, the patient's weight and the doctor's treatment plan. Generally speaking, the initial treatment phase may require frequent administration, while later treatments may require administration at longer intervals depending on the condition. Therefore, the cost of treatment will vary depending on the length of the treatment course and the frequency of administration.
Overseas, the original drug of durvalumab has a higher price. The common specification is 120mg/2.4mL, and the price per box is about more than one thousand US dollars. Due to factors such as import taxes and transportation costs, the price in the domestic market will be relatively high. This difference requires patients to comprehensively consider factors such as treatment costs, medication cycles, and treatment effects when choosing purchase channels.
Since there are currently no generic drugs of durvalumab on the market, patients can only choose the original drug for treatment, which results in relatively high treatment costs. With the possible launch of generic drugs in the future, treatment costs are expected to be reduced to a certain extent, especially after the inclusion of medical insurance, the burden on patients is also expected to be reduced.
Reference: https://www.imfinzi.com/